论文部分内容阅读
氧疗全称氧气疗法(oxygen therapy),是临床上最为常规的针对缺氧的一种治疗方法。氧疗虽可直接纠正或辅助改善低氧血症及其对人体各系统的影响,但氧疗设施与氧疗方法自身的缺陷也可给本已危重的患者或基础疾病已近治愈的患者带来多种不利甚至更为致命的风险——医源性肺部感染。本文从药物经济学思维的角度探讨仿生学无风险氧疗耗材的临床特点及其对降低氧疗综合成本的实际意义。
The full name of oxygen therapy oxygen therapy (oxygen therapy), is the most clinically a treatment for hypoxia. Although oxygen therapy can directly correct or assist in the improvement of hypoxemia and its effects on the human body, the deficiencies of oxygen therapy and oxygen therapy can also give patients already critically ill or those with underlying diseases almost cured To a variety of adverse or even more deadly risks - iatrogenic pulmonary infection. This article discusses the clinical features of bionics risk-free oxygen therapy consumables and its practical significance to reduce the comprehensive cost of oxygen therapy from the perspective of pharmacoeconomics.